Everything below concerns Certificate of analysis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-02-18. Numbers and descriptions here follow the published literature rather than marketing material.
In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Freeze-dried cake or loose powder after lyophilization |
| Solubility | Freely soluble in water | Also dissolves in aqueous buffers; solutions are less durable than the powder |
| Typical storage temperature | Minus 20 degrees Celsius or below | Desiccated and protected from light; avoid repeated freeze-thaw cycles |
| Identity method | Electrospray mass spectrometry | Compared against the expected mass; paired with sequence or composition analysis |
| Purity method | Reverse-phase HPLC with ultraviolet detection | Reports main-peak percentage rather than peptide content by mass |
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
Warden III, who largely planned the USAF attacks; within ten minutes of the attacks by 21 F117 aircraft on 38 targets, Iraq had lost its communications and radar; Lt-Col David Deptula; in the first wave were 4 Saudi Arabian Tornado aircraft, 4 Grumman A-6 Intruder and SEAD McDonnell Douglas F-4G Wild Weasel V aircraft, 5 Northrop Grumman EA-6B Prowler aircraft to provide electronic jamming of the Iraq airspace, and 21 McDonnell Douglas F/A-18 Hornet aircraft, each which dropped the AGM-88 HARM anti-radiation missile, to destroy the Iraq surface to air missile capability; Tomahawk missiles were fired from battleships in the Gulf and submarines in the Red Sea; the General Dynamics F-111 had around four thousand gallons of fuel; before advanced guidance systems for munitions, munitions would land according to the circular error probability, which was around a half-mile for a B-17 in World War II; the first laser-guided munitions were the Pave Tack system, which debuted on the F-111 in 1982, first deployed by F-111 aircraft from RAF Lakenheath; Duncan Lennox, editor of Jane's Strategic Weapon Systems; Theodore Postol; on one evening, twenty-eight MIM-104 Patriot missiles were launched against five ballistic missiles, which had broken up on re-entry to the earth's atmosphere - hitting any of these fractured ballistic missiles was almost impossible, due to the unforeseen changing aerodynamics; Lt-Col George Cusimano, deputy director of the USAF joint; the joint also deployed synthetic-aperture radar, to give a fuller view of ground forces, from the AN/APG-76 Doppler radar; the ground picture could be relayed to ground forces, such as in the Battle of Khafji on 29 January 1991; Royal Scots 1st Battalion, with GKN Warrior tracked armoured vehicles and Major John Potter; the experimental Ferranti TIALD laser-guided munitions were deployed by RAF Panavia Tornado aircraft to destroy Iraq hardened aircraft shelters in February 1991; 39th Regiment Royal Artillery deployed the M270 Multiple Launch Rocket System (MLRS); the land battle began on 24 February 1991, watched by the DOAE in Surrey; the land war did not last long, and on 26 February 1991 retreating Iraqi vehicles and tanks were systematically destroyed by AGM-114 Hellfire missiles, launched from undetected Boeing AH-64 Apache helicopters, resulting in total destruction; the USS Wisconsin battleship fired at Failaka Island, with surveillance provided by its AAI RQ-2 Pioneer drone. Narrated by Edward Hardwicke, directed by Chris Haws, produced by Richard Melman, made by InCA Productions 18 August The Healing Mind, about the field of psychoneuroimmunology; psychiatrist Janice Kielcolt-Glaser of Ohio State University College of Medicine; psychologist Barrie R. Cassileth; chemical pathologist Malcolm Carruthers takes a blood sample from a candidate, who has been driven around Brands Hatch at 115 mph; Theodore Melnechuk of the University of California; the body's immune system - the phagocytes destroy foreign bacteria, the natural killer cells destroy the body's own cells that are too damaged, and the lymphocyte T cells and B cells remember pathogens, with a corresponding antibody; experimental psychologist Robert Ader of the University of Rochester Medical Center conducted research on rats in 1975, with cyclophosphamide, which weakens the immune system, and immunologist Nicholas Cohen; prolonged secretion of endogenous opioid peptides may lower the immune function; neuroscientist David L. Felten of the University of Rochester; psychoimmunologist Nick Hall of the University of South Florida College of Medicine and an experiment with drama students, where lowering of T cells was found; Kathleen Dillon of Western New England College, where an experiment measured Ig A of candidates who watched types of television content, and found that Ig A temporarily increased with amusing content; psychiatrist Fawzy Fawzy of the University of California; psychiatrist Margaret Kemeny of UCLA. Narrated by Geoff Watts (of Radio 4's former Science Now series, produced by Geoff Deehan in the 1970s), directed by Yavar Abbas, produced by Geoff Deehan, made by Sandlin Productions 25 August Spacesuit, the spacesuits that astronauts wore during the Apollo missions to the Moon, and whether such spacesuits would be advanced enough to be worn for future missions to Mars; by 2020, NASA expected to have landed on Mars; at sea-level, air pressure is 14 PSI; ILC Dover in Newark, Delaware has made all NASA spacesuits since the late 1960s; medical research at the Ames Research Center; Joe Kosmo, head of NASA spacesuit design; the invention of the defecation-mitten by Matthew Radnofsky; Bruce Webbon of the Ames Research Centre; the Johnson Space Center also worked on suit design. Directed by Patrick Uden, made by Uden Associates 1 September The Falls, about the Niagara Falls. Produced by Clare Odgers, made by the National Film Board of Canada and Primitive Features 8 September Re-inventing Japan, looking at Japan's success in applied science, contrasted with less success in pure science and whether Japan could enhance its pure science industry enough, which has connections with a country's own cultural values and outlook, and how Britain has excelled in pure science, but how much that university funding cuts could erode Britain's prowess in pure science; Japan few Nobel prizes, but excelled at applied science and exploiting others' research by reverse engineering; Canon had £6bn of sales, of which 40% were photocopiers, such as the L5; Hajime Mitarai, research director of Canon, and how Canon had eight product divisions, with their own engineering staff in each division, with process physicists and inorganic chemists; with Western science innovations, it often came from a set of individuals, whereas Japan's innovation culture revolved around much intense group cooperation, not individuals; Japan had only won five Nobel prizes since the 1950s - the US had won 135; a youthful Matt Ridley of The Economist; Fujitsu was the world's second-largest manufacturer of computers, and had bought ICL (which had been Ferranti) in 1990, and sold £10bn a year; Naoki Yokoyama and Takahiko Misugi of Fujitsu; Japan could not rely on other countries research anymore, and had to conduct more in-house research; Japan's culture was not greatly known for originality or taking risks, or being surprised; pathologist Sir Anthony Epstein and how Japan greatly revered tradition, and conformity, possibly viewing anyone who didn't likewise confirm as troublesome; electrical engineer Hiroya Fujisaki, of Tokyo University and known for the Fujisaki model, and that he thought that Japan's culture had historically eroded originality; the national research organisation Riken was formed in 1917, and made great progress, with a large cyclotron, and visited by Einstein in December 1922, but the US was suspicious after the war, and destroyed Riken's cyclotron; Minoru Oda, head of Riken from 1988 to 1993; the US distrusted Japan, and preferred Japan to work on mainly applied science; physicist Akira Tonomura at the Hitachi Advanced Laboratory, which had the world's largest electron microscope; Shojiro Asai of Hitachi; the Canon Advanced Research Laboratory; the Tsukuba Science City and the University of Tsukuba, built by the Japanese government for £6bn, and home of the Japanese ERATO science innovation agency; Genya Chiba, director of ERATO; Michio Nagai, former minister of education in the mid-1970s. Directed by Bob Bee, produced by Michael Wills (later Labour MP from 1997 to 2010 for North Swindon), and made by Juniper Productions 13 September Theme Park Heaven, Walt Disney; Sylvère Lotringer of Columbia University; Arrow Dynamics of California, with Dal Freeman Ron Toomer; David Lewis; Cedar Point, built by Custom Coasters International of Cincinnati; Eric Westin of Walt Disney Imagineering, and the Big Thunder Mountain Railroad ride; Marc Davis, who drew Tinkerbell in Peter Pan, and who worked on the Pirates of the Caribbean ride, which opened in 1967; Larry Lester and David Codiga of Universal Studios, and their earthquake Studio Tour and Backdraft rides; Dreamland in 1912; psychologist Timothy Leary; Douglas Trumbull and the Back to the Future: The Ride and Luxor Las Vegas; Stan Kinsey of SimEx-Iwerks; Michael Ryder and Thom Dickeson of Evans & Sutherland, and texture mapping onto polygons, a main feature of transportation simulations; Bob Stone of the Advanced Robotics Research Centre at the University of Salford. Narrated by Richard O'Brien, produced by Jerome Kuehl, directed by Graham Moore, made with WGBH and Open Media 22 September The Professor's New Clothes, a re-broadcast of an Australian documentary about Professor Vishwa Jit Gupta of Panjab University and his fraudulent work about paleontology of the Himalayas. Directed by Stephen Ramsey, produced by Janet Bell, and made by Film Australia 29 September The Gambler's Guide to Winning, the ways of deploying mathematical techniques to win in gambling, with probability theory methods developed by Prof Edward O. Thorp of University of California, Irvine; the disastrous 1967 Grand National, where nearly all the horses fell at the 23rd fence; Frank Honywill George of Brunel University; Ralph Abraham of University of California, Santa Cruz; Peter A. Griffin of California State University, Sacramento; the gambler's fallacy; J. Doyne Farmer of the Santa Fe Institute. Narrated by Andrew Burt, directed by Julian Nott (son of the Conservative former defence secretary Sir John Nott, who later composed the music for Wallace and Gromit films such as The Wrong Trousers), produced by Jenny Barraclough, made by Peninsula Films 6 October Superpowers?, with Ray Hyman, about the international group of sceptics Committee for Skeptical Inquiry, who dispute topics such as UFOs, made by Open Media 13 October The Lean Burn Machine, about the development of catalytic converters for automotive engines, and how they cause more fuel to be burned than before, and the British engineer Geoffrey West who has produced an alternative, but faced restrictions from EC (EU) legislation; Europe introduced pollution legislation in July 1992; California had the worst vehicle pollution in the US, notably LA; the Clean Air Act; Rob Searles of Johnson Matthey; German environment minister Bernd Schmidbauer - Germany had over two-thirds of European car exports to the US; French physicist Hubert Curien, Minister of Higher Education, Research and Innovation from 1988 to 1993; chemistry graduate Margaret Thatcher being interviewed on 2 March 1989 on the BBC, and lean-burn engines; Bernard Bertrand, head of engine development of Peugeot; Shillington of BL; the new EC legislation in 1992 would outlaw lean-burn powered cars; Dutch automotive writer Gerard Sauer. Narrated by Nick Ross, directed by Nick Abson and Simon Broom, produced by Michael Blakstad (Editor from 1974 of Tomorrow's World), made by Workhouse 20 October The Elements, the poet Roger McGough narrates poetry for each element and how the Periodic Table came to be formed; 5% of the Earth's crust is iron; xenon is found in strobe lights; argon is in domestic incandescent light bulbs; the light bulb filament is tungsten, but reserves of tungsten are low. Directed by Ian Duncan, produced by David Dugan, made by Windfall Films (part of Argonon). Shown on 25 November 1992 on The Nature of Things in Canada 27 October The Strange Case of Crop Circles, an update to the documentary made in 1990, looking at why the 250 crop circles that appeared in the summer, that around 50% of the circles appeared in Wiltshire; the phenomenon took off after a circle near Westbury was pictured in a local newspaper in 1980; Tim Carson charged £1 per visitor to a circle in 1990, and 7,000 visited the Eastfield Pictogram at Alton Barnes, near Milk Hill; Steve Woolgar; Sir Francis Graham-Smith of the Royal Society, who dismissed those people interested in crop circles as mixed company who talked a lot of rubbish and it was a profit-less business to get involved with people who were completely hooked on the unknown; Serena Roney-Dougal; a youthful-looking Matt Ridley of The Economist said that since episodes with nuclear power in the 1970s, people had questioned evidence that scientists had told them; physicist Terence Meaden, who founded TORRO; Yoshi-Hiko Ohtsuki of Waseda University, who researched ball lightning. Narrated by Gavin Weightman, directed by Jill Freeman, and produced by her husband Michael Wills, made by Juniper Productions 3 November Human Waste, new ways of treating excrement such as dry compost toilets, oxidation pools and greenhouses. Directed by Kate Woods (Australian), made by John Blake Associates
== Education and career == Eberlin is the daughter of Marcos Nogueira Eberlin, a Brazilian chemist at the University of Campinas. She was born in Campinas, and she earned her bachelor's degree in 2007 from the University of Campinas. During her undergraduate studies, she did summer research in mass spectrometry at Purdue University, where her father also had research ties. She later enrolled at Purdue for her doctorate, which she completed in 2012. Her dissertation, Developments in ambient mass spectrometry imaging and its applications in biomedical research and cancer diagnosis, was supervised by R. Graham Cooks. After postdoctoral research at Stanford University with Richard Zare, she joined the faculty at the University of Texas at Austin in 2015 in the Department of Chemistry. She joined Baylor College of Medicine as Associate Professor in 2021.
This results in adrenal suppression and atrophy and, upon glucocorticoid discontinuation, temporary adrenal insufficiency. Similarly, CPA both in animals and humans can weakly reduce ACTH and cortisol levels and decrease adrenal gland weight as well as cause adrenal insufficiency with discontinuation. These findings suggest that CPA possesses weak glucocorticoid properties. CPA has been reported to be an antagonist of the glucocorticoid receptor (GR) in vitro and may reduce adrenal cortisol and corticosterone production by weakly inhibiting the enzymes 3β-hydroxysteroid dehydrogenase and 21-hydroxylase. These are antiglucocorticoid actions. However, metabolites of CPA, for instance 15β-hydroxycyproterone acetate, may have differing activities. Both cyproterone and CPA have been found to possess glucocorticoid effects, and based on studies in mice, it has been suggested that CPA has approximately one-fifth of the potency of prednisone as a glucocorticoid. The glucocorticoid effects of CPA in humans appear to be less significant than those in animals. Megestrol acetate, medroxyprogesterone acetate, and chlormadinone acetate are all steroidal progestins of the 17α-hydroxyprogesterone family and close analogues of CPA which similarly possess glucocorticoid properties and the potential for producing adrenal insufficiency upon discontinuation.
Sources: en.wikipedia.org
It has been particularly successful at analyzing "decoy" structures from ab initio structure prediction. These decoys are notorious for getting local fragment motif structure correct, and forming some kernels of correct 3D tertiary structure but getting the full length tertiary structure wrong. In this twilight remote homology regime, Mammoth's e-values for the CASP protein structure prediction evaluation have been shown to be significantly more correlated with human ranking than SSAP or DALI. Mammoths ability to extract the multi-criteria partial overlaps with proteins of known structure and rank these with proper E-values, combined with its speed facilitates scanning vast numbers of decoy models against the PDB data base for identifying the most likely correct decoys based on their remote homology to known proteins.
== External links == Gas+chromatography-mass+spectrometry at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Golm Metabolome Database, a mass spectral reference database of plant metabolites
Drugs administered through topical application can act locally or systemically. However, the drug molecules must first be retained in and penetrate the surface layer of the skin. Absorption of the drug through the skin surface is a passive process of diffusion. Skin penetration of the drug can take place by passive diffusion directly through the epidermis (via transcellular or intercellular routes), or absorption through shunt routes (diffusion through hair follicles and sweat glands). Initially, drug absorption may take place via the transfolliar route. After the drug reaches a steady state, transepidermal absorption may replace transfolliar absorption as the main pathway for absorption. Drug absorption through the skin varies depending on the concentration gradient between the surface of the skin and the body, with a higher rate of absorption resulting from a greater concentration gradient. The rate of drug absorption can be maintained at a constant level by ensuring that the drug concentration at the surface of the skin remains consistently and substantially greater than that in the body. The rate of penetration of the drug across the skin barrier depends on the physiological factors, physicochemical properties of the drug, and gel characteristics. Physiological factors include skin properties, size of application area, frequency and force of application. Physicochemical properties of the drug include drug solubility, affinity for the skin, and metabolism. Gel characteristics include stability, thermodynamic activity, and occlusive properties.
Other mechanism how T cells are suppressed by CAFs is high expression of checkpoint molecules such as PD-L1, PD-L2, B7-H3/H4, galectins and the enzyme IDO. CAFs in pancreatic cancer upregulate PD-1, CTLA-4 or TIM-3 on both CD4+ and CD8+ T cell surfaces.
Sources: en.wikipedia.org
The dry powder is the stable form and the dissolved form is comparatively fragile. Freezing a solution slows degradation but does not stop it, and repeated freezing and thawing adds further stress. Many laboratories therefore prepare small single-use portions rather than storing one large volume.
It describes the share of the chromatographic signal belonging to the main peak, not the mass fraction of peptide in the vial. Water, counter-ions such as acetate or trifluoroacetate, and residual solvents account for part of the weight of a lyophilized lot. Peptide content by mass is a separate measurement and is often reported alongside purity.
Mass spectrometry is the primary check, because the measured mass can be compared with the expected value for the fifteen-residue chain. Sequence analysis or amino acid composition provides an independent confirmation. Purity testing alone does not establish identity, since a mixture of unrelated short peptides can still produce a clean-looking chromatogram.
The standard approach is reverse-phase high-performance liquid chromatography, reported as a percentage of total peak area. Because that figure alone says little about the nature of the impurities, the accompanying chromatogram is normally the more useful document for judging a batch.